VALPOVIB CR 500 *SODIUM VALPROATE 333mg. IP + VALPROIC ACID 145mg. IP

Valpovib CR 500 tablets combine sodium valproate and valproic acid for the management of epilepsy seizures. Main uses: monotherapy and adjunctive therapy of complex partial seizures occurring alone or with other seizure types; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures.

Common side effects of Valpovib CR 500 Tablet include nausea and vomiting; abdominal pain and indigestion; dizziness and drowsiness; hair loss (alopecia); tremor; blurred vision or double vision. Get medical help at once if you notice liver damage or hepatic failure, especially in the first six months of treatment; pancreatitis, including serious bleeding cases; birth defects, reduced IQ and neurodevelopmental problems with exposure during pregnancy.

Each Valpovib CR 500 tablet contains Sodium Valproate 333 mg + Valproic Acid 145 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Valpovib CR 500 Tablet only as your doctor advises.

The MRP of Valpovib CR 500 Tablet is ₹99.75 for a pack of 10 (Alu Strip). For chemists and distributors, the PTR is ₹76 and the PTS is ₹68.4.

Each Valpovib CR 500 tablet contains Sodium Valproate 333 mg + Valproic Acid 145 mg. It comes in a pack of 10 (Alu Strip).

Both ingredients in the tablet release the valproate ion in the body. Valproate is thought to work in epilepsy by increasing the amount of gamma-aminobutyric acid (GABA) in the brain, a natural chemical that helps keep nerve signals under control. Sodium valproate provides the larger share of the valproate in the tablet, while valproic acid adds to that amount. The controlled-release form is designed to release the medicine slowly.

Must not be used by patients with liver disease or significant liver dysfunction. Must not be used by patients with known mitochondrial disorders caused by POLG gene mutations and children under two years suspected of a POLG-related disorder. Must not be used by patients with known urea cycle disorders. Must not be used by patients allergic to valproate. Must not be used to treat women with epilepsy who are pregnant or who plan to become pregnant unless other medicines have failed to give adequate seizure control or are otherwise unacceptable.

Valpovib CR 500 Tablet is a brand of Vibcare Pharma, sold through its Mind division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.